Multi-factorial approach associated with a new 'on/off' Orlistat® use in a weight loss maintenance programme: 4 years follow-up

Obesity Facts

Volumn 4, Issue 3, 2011, Pages 191-196

  Makoundou, Vincent ^a   Pataky, Zoltan ^a   Bobbioni Harsch, Elisabetha ^a   Gachoud, Jean Pierre ^b   Habicht, Franck ^a   Golay, Alain ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Roche Pharma Schweiz AG   (Switzerland)

Author keywords

Multi factorial approach; Orlistat ; Weight loss maintenance

Indexed keywords

GLUCOSE; INSULIN; TETRAHYDROLIPSTATIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DISEASE CONTROL; DRUG EFFICACY; FEMALE; FOLLOW UP; GLUCOSE TRANSPORT; HEALTH PROGRAM; HUMAN; INSULIN SENSITIVITY; MALE; OBESITY; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; ANTI-OBESITY AGENTS; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LACTONES; MALE; OBESITY; RECURRENCE; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT LOSS;

EID: 79960151834     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000329409     Document Type: Article

References (26)

1. Haslam DW, James WPT: Obesity. Lancet 2005; 366:1197-1209. (Pubitemid 41393598)
2. Hainer V, Toplack H, Mitrakou A: Treatment modalities of obesity. What fits whom. Diabetes Care 2008;31(suppl 2):S269-S277.
3. Bobbioni-Harsch E, Sztajzel J, Barthassat V, Makoundou V, Gastaldi G, Sievert K, Chassot G, Huber O, Morel P, Assimacopoulos-Jeannet, Golay A: Independent evolution of heart autonomic function and insulin sensitivity during weight loss. Obesity 2009;17:247-253.
4. Stern JS, Hirsch J, Blair SN, Foreyt JP, Frank A, Kumanyika SK, Madans JH, Marlatt GA, St Jeor ST, Stunkard AJ: Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res 1995;3:591-604.
5. Perri MG: The maintenance of treatment effects in the long-term management of obesity. Clin Psychol Sci Pract 1998;5:526-543. (Pubitemid 128540028)
6. Institute of Medicine, National Academy of Sciences. Weighing the Options: Criteria for Evaluating Weight Management Programs. Washington, DC, Government Printing Office, 1995.
7. Wing RR, Hill JO: Successful weight loss maintenance. Annu Rev Nutr 2001;21:323-341 (Pubitemid 32695275)
8. Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL: A self-regulation program for maintenance of weight loss. N Engl J Med 2006;355:1563-1571. (Pubitemid 44547807)
9. Lahti-Koski M, Männistö S, Pietinen P,Vartiainen E: Prevalence of weight cycling and its relation to health indicators in Finland. Obes Res 2005; 13:333-341.
10. Stevens J, Truesdale K P, McClain JE, Cai J: The definition of weight maintenance. Int J of Obes 2006;30:391-399.
11. Golay A, Laurent-Jaccard A, Habicht F, Gachoud JP, Chabloz M, Kammer A, Schutz Y: Effect of orlistat in obese patients with binge eating disorder. Obes Res 2005;13:1701-1708.
12. Buclin-Thiébaud S, Pataky Z, Bruchez V, Golay A: New psycho-pedagogic approach to obesity treatment: a 5-year follow-up. Patient Educ Couns 2000;79:333-337.
13. Golay A, Buclin S, Ybarra J, Toti F, Pichard C, Picco N, De Tonnac N, Allaz AF: New interdisciplinary cognitive-behavioural nutritional approach to obesity treatment: a 5-year follow-up study. Eat Weight Disord 2004;9:29-34.
14. Amati F, Barthassat V, Miganne G, et al: Enhancing regular physical activity and relapse prevention through a 1-day therapeutic patient education workshop: A pilot study. Patient Educ Couns 2007;68:70-78. (Pubitemid 47126792)
15. Golay A, Lagger G, Giordan A: Motivating patients with chronic diseases. J Med Person 2007; 5:57-63.
16. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-223. (Pubitemid 9249478)
17. Garner DM, Olmstead MP, Polivy J: Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eating Dis 1983;2:15-34.
18. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370. (Pubitemid 13098606)
19. Ward LC, Heitmann BL: Assessment of body composition by bioelectrical impedance analysis without the need for measurement of height. Clin Nutr 2001;20:21-26. (Pubitemid 32162348)
20. Wing RR, Phelan S: Long-term weight loss maintenance. Am J Clin Nutr 2005;82:222-225.
21. The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention. Phase II. Arch Intern Med 1999;157:657-667.
22. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J: Long-term weight loss and changes in blood pressure. Results of the Trials of Hypertension Prevention. Phase II. Ann Intern Med 2001;134:1-11. (Pubitemid 32037337)
23. Horvath K, Jeitler K, Siering U ,Stich AK, Skipka G, Gratzer TW, Siebenhofer A: Long-term effects of weight-reducing interventions in hypertensive patients. Systematic review and meta-analysis. Arch Intern Med 2008;168:571-580. (Pubitemid 351468391)
24. Klein S, Burke LE, Bray GA, Blair S, Allisson DB, Pi-Sunyer X, Hong Y, Ekel RH: Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004;110:2952-2967. (Pubitemid 39473623)
25. Kelley DE, Wing R, Buonocore C,Sturis J, Polonsk K Fitzsimmons M: Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993;77:1287-1293. (Pubitemid 23345484)
26. Rössner S, Sjöstrom L, Noack R, Meiden AE, Noseda G: Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000;8:49-61.